Cat. No. Name Size Price Add Cart
KI0010TGX-2215 mg$130
TGX-22125 mg$520
TGX-221100 mg$1392

Chemical Characteristic

Product NameTGX-221
CAS No.663619-89-4
Molecular Weight 364.44
FormulaC21H24N4O2
Chemical Name(+/-)-7-Methyl-2-(morpholin-4-yl)-9-(1-phenylaminoethyl)pyrido[1,2-a]pyrimidin-4-one
Smilesc12nc(cc(=O)n1cc(cc2C(C)Nc1ccccc1)C)N1CCOCC1
Chemical Structure

Biological activities

TGX-221 is a potent and selective phosphoinositide 3-kinase (PI3K) p110β inhibitor with an IC50 of 8.5 nM. The IC50 value for TGX-221 against class I PI3K catalytic isoform p110α is 5 µM. In J774.2 macrophage cells, TGX-221 (50 nM) partially attenuates insulin-induced phosphorylation of Ser473 of protein kinase B (PKB).[1] TGX-221 (0.1-2.5 µM) reduces the Ca2+ signal with about 50% in aspirin-treated, Fura-2-loaded platelets. TGX-221 also potently suppresses glycoprotein VI (GPVI)-induced InsP3 production and Akt phosphorylation in aspirin-treated human platelets. In addition, platelet treatment with PIK-75 or TGX-221, alone or in combination, suppresses convulxin- or C-reactive protein (CRP)-induced P-selectin expression with 40-50%, i.e. to the same extent as does wortmannin or LY-294002.[2] TGX-221 (3+3 mg/kg+mg/kg/hour) significantly improves blood flow in FeCl3-induced arterial thrombosis in mice. Vascular patency (non-occluded/total arteries) is also significantly improved by treatment with the 3+3 dose of TGX-221 compared to vehicle, but there is no significant benefit with the doses of 0.3+0.3 or 1+1. Tail bleeding time in mice increases significantly in response to TGX-221 administered at the 3+3 dose (median 1560 seconds) and the 1+1 dose (median 1305 seconds) compared to vehicle (median 225 seconds). Renal bleeding time increases significantly in mice treated with all three doses of TGX-221 compared to vehicle. The plasma TGX-221 levels in mice are 0.85 µM when mice are treated with TGX-221 at a dose of 1 mg/kg and given an infusion of TGX-221 at 1 mg/kg/hour for 45 minutes.[3]

References

[1] Chaussade C et al. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J. 2007, 404(3): 449-458.
[2] Gilio K, et al. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. J Biol Chem. 2009, 284(49): 33750-33762
[3] Bird JE, et al. Bleeding response induced by anti-thrombotic doses of a phosphoinositide 3-kinase (PI3K)-β inhibitor in mice. Thromb Res. 2011, 127(6): 560-564.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.